Maersk cautious on Strait of Hormuz shipping despite US-Iran ceasefire
COPENHAGEN, April 8 (Reuters) – Maersk said on Wednesday the two-week ceasefire agreed between the U.S. and Iran…
Danske Bank Opens New Lisburn Branch
Danske Bank has unveiled its new Lisburn branch, following its relocation to Bow Street Mall. The branch brings…
LEGO Botanicals Rumoured June 2026 Sets
The LEGO Botanicals theme is branching out into new territory this summer with a trio of rumoured sets…
Has India Disrupted Weight-Loss Drug Market? What Triggered 90% Slide In Generic Ozempic Prices
India’s weight-loss and diabetes drug market has been shaken up after prices of semaglutide, the molecule behind Ozempic…
Inflation data seen as neutral – Danske Bank
Danske Research Team notes that Canadian headline inflation rose to 2.4% year-on-year in March, slightly below expectations, while…
Hims & Hers (HIMS) Stock Up 49% in Five Days on FDA Peptide Review and Novo Nordisk Deal
TLDR Hims & Hers (HIMS) stock surged as much as 49% in five trading sessions, with an 11%…
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly’s and Novo’s GLP-1 Duopoly
You probably already know that pharmaceutical powerhouses Novo Nordisk (NVO 0.15%) and Eli Lilly (LLY 0.71%) dominate the…
Consumer Confidence Falls In Third Quarter – Danske Bank
Consumer confidence in Northern Ireland declined in the third quarter of 2025, as people reported feeling less optimistic…
Novo Nordisk’s Sickle Cell Success Charts a New Path Beyond Blockbuster Drugs
Novo Nordisk’s etavopivat reduces sickle cell crises by 27% in Phase 3 trial, marking a key diversification move…
Hike call postponed to June – Danske Bank
Danske Research Team reports that Reuters sources suggest the Bank of Japan (BoJ) is likely to hold off…
Weatherford and Maersk Training Announce Partnership to Advance MPD Training
Weatherford have announced a strategic partnership with Maersk Training, a world-class provider of oil and gas training solutions, to jointly develop…
Is its obesity drug dominance strong enough to sustain long-t
Novo Nordisk leads the GLP-1 market with Wegovy and Ozempic, but can it fend off rivals like Eli…